Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases
N/A
This is a prospective, open label, controlled, single center real-world obs...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2025-05-19
Trial ID
NCT07135778
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
PHASE2
RATIONALE: Patient abstract not available
PURPOSE: Patient abstract not av...
Status
Completed
Location
NYU School of Medicine's Kaplan Comprehensive Cancer Center
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
PHASE3
This trial is a registrational Phase III, randomized, open-label, multicent...
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
PHASE1
This open-label Phase I study is designed to determine the maximum tolerate...